7899-7820 Intertrigo

DBQ: Link to Index of DBQ/Exams by Disability for DC 7820

Definition

A superficial dermatitis occurring in the folds of the skin. The condition is also known as eczema intertrigo.

Etiology

Obesity may be a predisposing factor of intertrigo due to moisture, friction, warmth and sweat retention in skin folds. It may also be caused by a fungal or yeast infection.

Signs & Symptoms

Manifestations may include red, moist, well-marked patches in the armpits, navel, groin or buttock/thigh fold. The patches are rimmed with small, red bumps occurring with maceration, burning, itching and sometimes breakdown of the skin (erosions), fissures, exudation and secondary infection.

Tests

Physical examination may be sufficient to diagnose the condition. Other tests that may be performed include serum laboratory tests, or laboratory analysis of tissue from the lesions.

Treatment

Antibiotics may be prescribed if a secondary bacterial infection develops in the area. Treatment may include long-term medication use, which may include antifungal medications. Proper physician follow-up examination may be required if the individual is on long-term antifungal medication. Patient education may be necessary to instruct the patient on good hygiene techniques to keep the affected area clean and dry.

Residuals

The infections associated with intertrigo are rarely life threatening. They can range from mild to severe, and can often persist or recur.

Special Considerations

  • When 38 CFR 4.118 offers variable methods to evaluate a skin condition, assign a single evaluation using the criteria that results in the highest rating. 

  • Consider this condition pursuant to 38 CFR 4.27 and 38 CFR 4.20, when applicable. Analogous ratings are utilized when a specific disability is not listed in 38 CFR Part 4. Certain hyphenated codes do not necessarily denote analogous ratings – a hyphenated DC may also be used to identify the proper evaluation of a disability or a residual from disease. Diagnostic Codes (DCs) must be carefully selected as a condition specifically listed in the rating schedule may not be rated by analogy, unless otherwise directed (e.g., amyotrophic lateral sclerosis, multiple sclerosis).  When multiple DCs apply to a given disability, consider whether separate evaluations are warranted, and/or which DC will result in the most advantageous outcome for the claimant.

Notes

  • 38 CFR 4.118 (a) For the purposes of this section, systemic therapy is treatment that is administered through any route (orally, injection, suppository, intranasally) other than the skin, and topical therapy is treatment that is administered through the skin. 

  • 38 CFR 4.118 (b) Two or more skin conditions may be combined in accordance with 38 CFR 4.25 only if separate areas of skin are involved. If two or more skin conditions involve the same area of skin, then only the highest evaluation shall be used.